Correlation Between Algernon Pharmaceuticals and BioCardia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and BioCardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and BioCardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algernon Pharmaceuticals and BioCardia, you can compare the effects of market volatilities on Algernon Pharmaceuticals and BioCardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of BioCardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and BioCardia.

Diversification Opportunities for Algernon Pharmaceuticals and BioCardia

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Algernon and BioCardia is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and BioCardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCardia and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with BioCardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCardia has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and BioCardia go up and down completely randomly.

Pair Corralation between Algernon Pharmaceuticals and BioCardia

If you would invest  5.85  in Algernon Pharmaceuticals on August 28, 2024 and sell it today you would lose (0.15) from holding Algernon Pharmaceuticals or give up 2.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy0.0%
ValuesDaily Returns

Algernon Pharmaceuticals  vs.  BioCardia

 Performance 
       Timeline  
Algernon Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Algernon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Algernon Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
BioCardia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioCardia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BioCardia is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Algernon Pharmaceuticals and BioCardia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Algernon Pharmaceuticals and BioCardia

The main advantage of trading using opposite Algernon Pharmaceuticals and BioCardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, BioCardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCardia will offset losses from the drop in BioCardia's long position.
The idea behind Algernon Pharmaceuticals and BioCardia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stocks Directory
Find actively traded stocks across global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data